Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
4-Methoxypiperidine → 3-Chloro-5-({7-[(2E)-4-(4-methoxypiperidin-1-yl)but-2-enoyl]-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-yl}amino)phenol
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 4-Methoxypiperidine | HCID 77666 | — |
| 반응물 | 4-Bromocrotonic acid | HCID 6436411 | — |
| 반응물 | 3-Chloro-5-(5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-ylamino)phenol hydrochloride | HCID 66850088 | — |
| 생성물 | 3-Chloro-5-({7-[(2E)-4-(4-methoxypiperidin-1-yl)but-2-enoyl]-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-yl}amino)phenol | HCID 58116920 | — |
반응 단계
In analogy to Example 130, the title compound was prepared from (2E)-4-bromobut-2-enoic acid (84 mg, 0.41 mmol), 3-chloro-5-(5,6,7,8-tetrahydropyrido[4′,3′:4,5]thieno[2,3-d]pyrimidin-4-ylamino)phenol hydrochloride from Example 65A (100 mg, 0.27 mmol) and 4-methoxypiperidine (50 mg, 0.43 mmol) to yield 33 mg (23%).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08524722B2 |
| 출처 데이터셋 | uspto-grants-2013_09 |
| ORD ID | ord-0d21c9a379f14f5599eb728eb61fe376 |
| 출처 메모 | uspto-grants-2013_09 |